56. Behcet disease Clinical trials / Disease details


Clinical trials : 76 Drugs : 110 - (DrugBank : 32) / Drug target genes : 36 - Drug target pathways : 116

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00167583
(ClinicalTrials.gov)
November 20049/9/2005Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet's Disease (INCYTOB)Phase III Study of Recombinant Human Interferon-alpha2a Versus Cyclosporin A for the Treatment of Ocular Behcet's Disease - a National,Randomised, Single-masked Controlled Trial (INCYTOB)Behcet's Disease;Panuveitis;Posterior Uveitis;Retinal VasculitisDrug: Cyclosporin A;Drug: Interferon-alpha2aUniversity Hospital TuebingenNULLCompleted18 Years75 YearsAll37Phase 3Germany